UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000031459
Receipt number R000035786
Scientific Title Phase II study of safety and efficacy of alternating R-CHOP and R-HDMA therapy in high-risk diffuse large B-cell lymphoma
Date of disclosure of the study information 2018/03/01
Last modified on 2021/04/02 12:57:40

No. Disposal Last modified on Item of update
1 Insert 2018/02/24 15:23:41
2 Update 2019/03/17 18:29:06 Recruitment status
Date of IRB
Last follow-up date
3 Update 2019/08/27 13:01:55 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email
Name of person sending information
Name of person sending information
Email
Organization
Organization
Address
Address
Tel
Email
4 Update 2019/10/16 14:35:52 UMIN ID1
5 Update 2020/08/27 13:06:49
Last name of contact person

Last name of contact person
Email
Name of person sending information
Name of person sending information
6 Update 2020/08/27 13:09:23 UMIN ID2
7 Update 2021/04/02 12:56:08 Recruitment status
8 Update 2021/04/02 12:57:40 Number of participants that the trial has enrolled